Percutaneous renal angioplasty and stenting: application of embolic protection device in patients with normal renal function

Xiao-qiang TONG,Min YANG,Ming YIN,Jian WANG,Li SONC,Chao WANG,Yong-xing Lü,Hong-liang SUN,Ying-hua ZOU
DOI: https://doi.org/10.3969/j.issn.1008-794X.2007.07.005
2007-01-01
Abstract:Objective: To investigate the value of embolic protection device (EPD)in renal artery stenting (RAS)for the patients with normal renal function. Methods: Total 24 patients (26 renal arteries) suffering from renal artery stenosis with normal serum creatinine were divided into two groups: EPD group (n = 12)and non-EPD group (n = 12).Serum creatinine was calculated and analized statistically between the two groups, 1 month and 6months after stenting respectively, and followed by comparisons taking inside of each group and between both groups. Results: Serum creatinine of the EPD and non-EPD groups before, 1 month and 6 month after stenting were(99.18 + 18.26) μmol/L, (101.73 ± 12.65) μmol/L, (96.82 ± 15.81) μmol/L and (100.18 ± 19.81) μmol/L, (107.36 ± 29.49) μmol/L, (127.64 ± 88.05) μmol/L, respectively; showing no significant difference inside each group individually (P > 0.05), and also no statistically significant difference between the two groups(P > 0.05). Conclusion: For the patients suffering from renal artery stenosis with normal serum creatinine, application of EPD may have no impact on renal function. Further evaluation is needed.
What problem does this paper attempt to address?